Scott L. Schissel, M.D., D.Phil.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sphingomyelin Phosphodiesterase | 8 | 1998 | 94 | 0.780 |
Why?
|
| Social Justice | 1 | 2021 | 421 | 0.620 |
Why?
|
| Reimbursement Mechanisms | 1 | 2021 | 662 | 0.550 |
Why?
|
| Pulmonary Fibrosis | 2 | 2009 | 552 | 0.470 |
Why?
|
| Carboxypeptidases | 1 | 2009 | 183 | 0.350 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3041 | 0.300 |
Why?
|
| Lipoproteins, LDL | 3 | 1998 | 668 | 0.280 |
Why?
|
| Muscle Cells | 1 | 2006 | 200 | 0.280 |
Why?
|
| Arteriosclerosis | 3 | 1998 | 1193 | 0.250 |
Why?
|
| Sphingomyelins | 3 | 1998 | 115 | 0.240 |
Why?
|
| Aorta | 2 | 2009 | 2114 | 0.220 |
Why?
|
| Telomerase | 1 | 2006 | 744 | 0.210 |
Why?
|
| Pulmonary Alveolar Proteinosis | 2 | 2011 | 43 | 0.200 |
Why?
|
| CHO Cells | 4 | 1998 | 1442 | 0.190 |
Why?
|
| Cholesterol Esters | 2 | 1996 | 88 | 0.180 |
Why?
|
| Fibroblasts | 2 | 2009 | 4286 | 0.180 |
Why?
|
| HMGA1a Protein | 1 | 2018 | 67 | 0.170 |
Why?
|
| Lysosomes | 4 | 1998 | 946 | 0.160 |
Why?
|
| Repressor Proteins | 1 | 2009 | 3089 | 0.160 |
Why?
|
| Zinc | 2 | 1998 | 695 | 0.150 |
Why?
|
| Cytoplasmic Granules | 1 | 1998 | 619 | 0.140 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1995 | 217 | 0.140 |
Why?
|
| Lung | 3 | 2011 | 9781 | 0.130 |
Why?
|
| Macrophages, Peritoneal | 1 | 1995 | 275 | 0.130 |
Why?
|
| Dyspnea | 2 | 2011 | 1256 | 0.120 |
Why?
|
| Burnout, Professional | 1 | 2021 | 637 | 0.120 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2011 | 905 | 0.100 |
Why?
|
| Cricetinae | 4 | 1998 | 2597 | 0.090 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2008 | 101 | 0.090 |
Why?
|
| Endothelium, Vascular | 2 | 1998 | 4636 | 0.080 |
Why?
|
| Bleomycin | 1 | 2009 | 512 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2021 | 3179 | 0.080 |
Why?
|
| Lipoproteins, VLDL | 3 | 1998 | 229 | 0.080 |
Why?
|
| Potassium | 1 | 1991 | 1332 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1998 | 2613 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 1991 | 905 | 0.070 |
Why?
|
| Mice, Inbred ICR | 2 | 1996 | 378 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 631 | 0.070 |
Why?
|
| Autoantibodies | 2 | 2011 | 2008 | 0.070 |
Why?
|
| Vasoconstriction | 1 | 2008 | 607 | 0.070 |
Why?
|
| Sepsis | 1 | 2018 | 2460 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 1276 | 0.060 |
Why?
|
| Physicians | 1 | 2021 | 4354 | 0.060 |
Why?
|
| Collagen | 2 | 2009 | 2694 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2008 | 1235 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2008 | 1621 | 0.060 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2008 | 817 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2009 | 3309 | 0.050 |
Why?
|
| Mice, Knockout | 4 | 2009 | 15258 | 0.050 |
Why?
|
| Animals | 14 | 2018 | 170894 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 2008 | 1952 | 0.050 |
Why?
|
| Lung Transplantation | 1 | 2009 | 1158 | 0.050 |
Why?
|
| Esterification | 2 | 1996 | 36 | 0.050 |
Why?
|
| Mice | 8 | 2018 | 81128 | 0.050 |
Why?
|
| Hexosaminidases | 1 | 1998 | 55 | 0.040 |
Why?
|
| Glucose | 1 | 1991 | 4303 | 0.040 |
Why?
|
| Faculty | 1 | 2021 | 349 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2008 | 1502 | 0.040 |
Why?
|
| Community-Acquired Infections | 2 | 2011 | 473 | 0.040 |
Why?
|
| Niemann-Pick Diseases | 1 | 1996 | 26 | 0.040 |
Why?
|
| Endotoxemia | 1 | 2018 | 218 | 0.040 |
Why?
|
| Hydrolysis | 1 | 1998 | 728 | 0.040 |
Why?
|
| Foam Cells | 1 | 1996 | 83 | 0.040 |
Why?
|
| Respiratory Function Tests | 2 | 2011 | 1671 | 0.040 |
Why?
|
| Hydroxycholesterols | 1 | 1995 | 24 | 0.040 |
Why?
|
| Leupeptins | 1 | 1995 | 142 | 0.040 |
Why?
|
| Ceramides | 1 | 1996 | 194 | 0.030 |
Why?
|
| Cycloheximide | 1 | 1995 | 361 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2018 | 904 | 0.030 |
Why?
|
| Aplysia | 1 | 1994 | 36 | 0.030 |
Why?
|
| Ganglia, Invertebrate | 1 | 1994 | 18 | 0.030 |
Why?
|
| Cheek | 1 | 1994 | 68 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 2018 | 552 | 0.030 |
Why?
|
| Leucine | 1 | 1995 | 602 | 0.030 |
Why?
|
| Internal Medicine | 1 | 2021 | 1006 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2018 | 735 | 0.030 |
Why?
|
| Mechanoreceptors | 1 | 1994 | 172 | 0.030 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 9927 | 0.030 |
Why?
|
| United States | 1 | 2021 | 67804 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 1998 | 652 | 0.030 |
Why?
|
| Hypotension | 1 | 2018 | 831 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1996 | 1792 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 966 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2018 | 1585 | 0.030 |
Why?
|
| Blood Vessels | 1 | 2018 | 1162 | 0.030 |
Why?
|
| Neurons, Afferent | 1 | 1994 | 515 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 1998 | 2336 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 1998 | 1472 | 0.030 |
Why?
|
| Buffers | 1 | 1991 | 157 | 0.030 |
Why?
|
| Lipoproteins | 1 | 1996 | 921 | 0.030 |
Why?
|
| Lactates | 1 | 1991 | 406 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 1991 | 344 | 0.020 |
Why?
|
| Humans | 9 | 2021 | 717280 | 0.020 |
Why?
|
| Cattle | 1 | 1996 | 4000 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 2267 | 0.020 |
Why?
|
| Rabbits | 1 | 1996 | 5143 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1991 | 2268 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2018 | 20097 | 0.020 |
Why?
|
| Muscles | 1 | 1994 | 1630 | 0.020 |
Why?
|
| Therapeutic Irrigation | 1 | 2010 | 306 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2018 | 2584 | 0.020 |
Why?
|
| Iloprost | 1 | 2008 | 29 | 0.020 |
Why?
|
| Neuropeptides | 1 | 1994 | 937 | 0.020 |
Why?
|
| Receptor, Endothelin A | 1 | 2008 | 61 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2006 | 11762 | 0.020 |
Why?
|
| Traction | 1 | 2008 | 103 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 6860 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1995 | 2816 | 0.020 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2008 | 121 | 0.020 |
Why?
|
| Transfection | 1 | 1996 | 6142 | 0.020 |
Why?
|
| Gels | 1 | 2008 | 437 | 0.020 |
Why?
|
| Glycolysis | 1 | 1991 | 818 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2008 | 314 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4480 | 0.020 |
Why?
|
| Lactic Acid | 1 | 1991 | 1126 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 14243 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2008 | 602 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 1791 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2008 | 907 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 13276 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 18738 | 0.020 |
Why?
|
| Cell Line | 2 | 1996 | 16693 | 0.020 |
Why?
|
| Macrophages | 2 | 1996 | 5814 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2008 | 22929 | 0.020 |
Why?
|
| Brain | 1 | 1991 | 25281 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2008 | 1008 | 0.020 |
Why?
|
| Cytokines | 1 | 2018 | 7223 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2008 | 1250 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2008 | 2858 | 0.010 |
Why?
|
| Kinetics | 1 | 1991 | 6805 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2010 | 1895 | 0.010 |
Why?
|
| Female | 4 | 2011 | 377934 | 0.010 |
Why?
|
| Radiography | 1 | 2011 | 7000 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 12435 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1991 | 8744 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2008 | 1901 | 0.010 |
Why?
|
| Pneumonia | 1 | 2010 | 2102 | 0.010 |
Why?
|
| Inflammation | 1 | 2018 | 10116 | 0.010 |
Why?
|
| Apolipoproteins C | 1 | 1998 | 59 | 0.010 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 1998 | 37 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 8925 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1998 | 444 | 0.010 |
Why?
|
| Ethylmaleimide | 1 | 1996 | 79 | 0.010 |
Why?
|
| Apolipoprotein C-III | 1 | 1998 | 226 | 0.010 |
Why?
|
| Sterol O-Acyltransferase | 1 | 1996 | 57 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1998 | 439 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1996 | 356 | 0.010 |
Why?
|
| Acyltransferases | 1 | 1998 | 306 | 0.010 |
Why?
|
| Receptors, LDL | 1 | 1998 | 543 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1998 | 23997 | 0.010 |
Why?
|
| Male | 2 | 2009 | 351399 | 0.010 |
Why?
|
| Interferons | 1 | 1998 | 680 | 0.010 |
Why?
|
| Rats | 1 | 1991 | 25092 | 0.010 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1996 | 448 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1998 | 1193 | 0.010 |
Why?
|
| Interleukins | 1 | 1998 | 803 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9047 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 1994 | 544 | 0.010 |
Why?
|
| Mammals | 1 | 1998 | 944 | 0.010 |
Why?
|
| Adolescent | 2 | 2011 | 85143 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 7074 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1998 | 11777 | 0.010 |
Why?
|
| Asthma | 1 | 2011 | 5941 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2008 | 8582 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 62344 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1994 | 1184 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 1998 | 1174 | 0.010 |
Why?
|
| Eating | 1 | 1994 | 1471 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 20435 | 0.000 |
Why?
|
| Cholesterol | 1 | 1996 | 2894 | 0.000 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1996 | 2961 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 3933 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1996 | 2977 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1998 | 13301 | 0.000 |
Why?
|